查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1864212

生物樣品處理市場按產品類型、最終用戶、應用、樣品類型和工作流程分類－2025-2032年全球預測

Biological Sample Handling Market by Product Type, End User, Application, Sample Type, Workflow - Global Forecast 2025-2032
出版日期: | 出版商: 360iResearch | 英文 188 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物樣本處理市場規模將達到 331.6 億美元，複合年成長率為 6.62%。

關鍵市場統計數據
基準年 2024 198.5億美元
預計年份：2025年 211.9億美元
預測年份 2032 331.6億美元
複合年成長率 (%) 6.62%

概述營運重點、品質壓力和跨職能決策需求，以建立生物樣本處理的策略架構。

現代生物樣本處理生態系統融合了科學嚴謹性、營運效率和嚴格的監管。實驗室、臨床機構、研究中心和工業研發團隊面臨日益成長的樣本完整性維護要求，涵蓋從採集到分析的整個過程。自動化、數位化和試劑化學的進步正在改變日常工作流程，而對可重複性和可追溯性的日益成長的需求則要求更嚴格的流程控制和檢驗的供應鏈。

透過自動化、試劑創新和數據驅動的監管鏈解決方案，展現檢體處理方式的變革性轉變。

生物樣本處理領域正經歷著一場變革性的轉變，其驅動力包括技術成熟、監管機構對資料完整性的重視以及臨床和科學研究終端使用者不斷變化的需求。自動化已從獨立儀器發展到整合採集、處理和儲存功能的流程平台，使檢查室能夠在提高通量的同時減少人為錯誤。試劑配方和試劑盒設計的同步進步正在提高各種檢測方法的穩定性和相容性，降低變異性並縮短檢驗時間。

評估2025年實施的關稅對檢查室採購、供應商策略和供應鏈韌性的累積營運和採購影響

2025年實施的新關稅措施增加了支持生物樣本處理的全球供應鏈的複雜性，影響了籌資策略和營運計畫。進口實驗室設備、耗材和某些試劑類別的關稅調整增加了依賴跨境採購的機構的到岸成本，迫使採購部門重新評估供應商選擇和庫存管理政策。為此，許多機構正在修訂其總體擁有成本 (TCO) 計算方法，以反映關稅、更長的前置作業時間和增加的物流風險。

整合產品、最終用戶、應用、檢體類型和工作流程等因素，這些因素共同驅動採購和檢驗的優先事項，從而提供可操作的細分洞察。

對細分市場的詳細分析揭示了產品類型、最終用戶、應用、樣本類型和工作流程如何影響樣本處理過程中的採購優先順序和創新應用。檢驗產品類型發現，耗材、儀器、試劑和試劑盒以及軟體和服務各自對買家有不同的價值提案。在儀器領域，隨著實驗室追求更高的通量和可重複性，自動移液系統、溫控離心機和渦旋攪拌機的需求顯著。同時，包括抗體、緩衝液和溶液、酵素以及標記和檢測試劑在內的試劑和試劑盒，對檢測性能和相容性起著決定性作用。最終用戶的多樣性影響著採購行為。學術研究機構、生物製藥公司、合約研究組織 (CRO)、受託研究機構檢查室和醫院在檢驗、通量和成本控制方面採用不同的標準。特別是診斷檢查室，又細分為臨床化學、血液學、微生物學和分子診斷，每個領域都有其獨特的處理要求。

了解美洲、歐洲、中東和非洲以及亞太地區的區域管理體制、製造能力和物流基礎設施如何創造不同的機會。

區域趨勢正在影響檢體處理的策略選擇，各機構在評估當地法規結構、製造地和物流基礎設施時都會做出相應調整。在美洲，需求模式反映了高通量臨床檢查室和生物製藥研發中心的多元化組合，這些機構優先考慮自動化、長期供應商關係以及快速獲取新型試劑。供應鏈整合和大規模合約服務供應商的存在進一步影響供應商的選擇和首選的商業模式。

識別供應商之間的競爭差異化因素，這些因素結合了檢驗的產品系列、服務模式和互通性，以減少分析前變異性。

在樣本處理生態系統中，競爭格局日益取決於企業提供涵蓋硬體、耗材、試劑和資訊服務的一體化提案主張的能力。擁有完善的品質系統、法規支援和清晰檢驗文件的供應商通常更受受監管的終端用戶青睞，而擁有模組化、可互通平台的供應商則更受高通量研究和工業客戶的青睞。投資於特定應用試劑盒、試劑和檢驗通訊協定的公司能夠降低採用門檻並提高客戶維繫，尤其是在診斷流程和受監管的藥物開發工作流程中。

為增強供應鏈韌性、規範驗證流程和提高自動化程度以降低分析前風險和營運風險，提出切實可行的建議

透過協調籌資策略、驗證計畫和跨職能管治，產業領導者可以即時採取切實可行的措施來加強其檢體處理流程。首先，建立嚴格的供應商選擇流程，評估批次間一致性文件、試劑穩定性數據和耗材可追溯性，並確保合約涵蓋關稅和物流風險。其次，優先投資自動化，以顯著減少人為錯誤並實現穩定的處理量，並將這些投資與培訓計劃相結合，使檢查室人員能夠有效地操作和維護自動化系統。

我們描述了一種嚴謹的混合方法調查方法，該方法結合了初步訪談、技術文獻綜述和專家檢驗，以確保研究結果的可操作性和準確性。

本研究途徑結合了結構化的初步研究和針對性的二次研究，旨在對生物樣本處理動態進行穩健且基於證據的評估。初步研究包括對實驗室主任、採購人員、品質保證專業人員和供應鏈經理進行訪談，以收集有關挑戰、推廣促進因素和檢驗障礙的第一手資訊。這些訪談旨在了解操作細節，例如工作流程瓶頸、試劑穩定性問題和儀器運轉率優先事項，並且所有訪談均匿名保密，以鼓勵受訪者坦誠作答。

最後，報告清楚地總結瞭如何透過協調投資自動化、檢驗的試劑和可靠的採購管道來確保檢體完整性和業務連續性。

摘要，生物樣本處理領域正處於轉折點，技術創新、監管審查和供應鏈趨勢相互交織，重新定義檢查室保護檢體完整性和加速發現的方式。積極投資於可互通自動化系統、檢驗的試劑系統和即時監管鏈監控的機構，將能夠更好地應對分析前變異性和合規性要求。同樣重要的是，鑑於關稅壓力和物流不確定性，對採購慣例實踐進行策略性重組，從而建立多元化的供應商組合和強大的區域夥伴關係關係。

目錄

第1章：序言

第2章調查方法

第3章執行摘要

第4章 市場概覽

第5章 市場洞察

  • 採用一次性生物製程技術，最大限度地減少生物製藥生產的交叉污染
  • 推出支援物聯網的低溫運輸監控設備，用於即時追蹤整個供應鏈中的樣品完整性
  • 隨著分散式就地檢驗的普及，需要可靠的樣本穩定和運輸解決方案。
  • 透過使用新型冷凍保護劑開發冷凍保存方法來改善長期儲存。
  • 實驗室自動化平台的發展，融合了人工智慧驅動的品管，用於樣品處理和數據管理。

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

8. 依產品類型分類的生物樣品處理市場

  • 消耗品
  • 裝置
    • 自動化移液系統
    • 溫控離心機
    • 渦流攪拌機
  • 試劑和試劑盒
    • 抗體
    • 緩衝液和溶液
    • 酵素
    • 標記和檢測試劑
  • 軟體和服務

9. 依最終使用者分類的生物樣品處理市場

  • 學術研究機構
  • 生物製藥公司
  • CRO（受託研究機構）
  • 診斷檢查室
    • 臨床化學
    • 血液學
    • 微生物學
    • 分子診斷
  • 醫院

第10章 生物工具處理市場（按應用領域分類）

  • 診斷
    • 實驗室測試
    • 照護端
  • 藥物發現與開發
  • 基因組學
  • 蛋白質體學

第11章 生物樣本處理市場（按樣品類型分類）

  • 血
  • 細胞
  • 組織
  • 尿

12. 依工作流程分類的生物樣本處理市場

  • 分析
  • 收藏
  • 過程
  • 貯存
  • 運輸

13. 各地區生物樣品處理市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第14章 生物工具處理市場（依組別分類）

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 各國生物樣本處理市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 2024年市佔率分析
  • FPNV定位矩陣，2024
  • 競爭分析
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Agilent Technologies, Inc.
    • Avantor, Inc.
    • Bio-Rad Laboratories, Inc.
    • PerkinElmer, Inc.
    • Sartorius AG
    • QIAGEN NV
    • General Electric Company
Product Code: MRR-757B1C9CB0B6

The Biological Sample Handling Market is projected to grow by USD 33.16 billion at a CAGR of 6.62% by 2032.

KEY MARKET STATISTICS
Base Year [2024] USD 19.85 billion
Estimated Year [2025] USD 21.19 billion
Forecast Year [2032] USD 33.16 billion
CAGR (%) 6.62%

Establishing the strategic context for biological sample handling by outlining operational priorities, quality pressures, and cross-functional decision imperatives

The contemporary ecosystem for biological sample handling sits at the intersection of scientific rigor, operational efficiency, and stringent regulatory oversight. Laboratories, clinical facilities, research centers, and industrial R&D teams face an expanding set of requirements to preserve sample integrity from collection through analysis. Advances in automation, digitization, and reagent chemistry are reshaping daily workflows, while heightened expectations around reproducibility and traceability demand tighter process controls and validated supply chains.

Against this backdrop, organizations must balance cost pressures with the imperative to minimize pre-analytical variability. Investments in instrumentation, consumables, and end-to-end workflow solutions increasingly reflect a strategic choice to reduce downstream assay failures and accelerate time to insight. As practices evolve, cross-functional collaboration among procurement, laboratory operations, quality, and informatics becomes vital to ensure that equipment selection, reagent sourcing, and storage protocols collectively support scientific objectives without introducing unmanageable complexity. This introduction frames the primary forces influencing decision-making and sets the stage for deeper analysis of technological shifts, policy impacts, and segmentation-specific dynamics that follow.

Mapping the transformative shifts reshaping sample handling through automation, reagent innovation, and data-driven chain-of-custody solutions

The landscape of biological sample handling is undergoing transformative shifts driven by technological maturation, regulatory emphasis on data integrity, and changing demand patterns from both clinical and research end users. Automation is moving beyond isolated instruments to integrated workflow platforms that combine collection, processing, and storage functions, enabling labs to scale throughput while reducing human error. Parallel advances in reagent formulations and kit design are improving stability and compatibility across diverse assay modalities, which in turn reduces variability and shortens validation timelines.

Data-centric approaches are becoming central; laboratory informatics systems and connected devices now enable real-time monitoring of sample chain-of-custody and environmental conditions. This connectivity supports risk-based quality management and allows organizations to detect and remediate deviations more quickly. Additionally, there is an increasing premium on modular solutions that can be configured to meet both high-throughput industrial needs and smaller, decentralized clinical settings. Taken together, these trends are reshaping procurement priorities, incentivizing scalable investments, and redefining the vendor landscape as suppliers compete to offer interoperable, validated systems that span multiple steps of the sample lifecycle.

Assessing the cumulative operational and sourcing impacts of tariff measures introduced in 2025 on laboratory procurement, supplier strategies, and supply chain resilience

The advent of new tariff measures in 2025 has introduced a layer of complexity to global supply chains that support biological sample handling, affecting procurement strategies and operational planning. Tariff adjustments on imported laboratory equipment, consumables, and certain reagent categories have increased landed costs for organizations that rely on cross-border sourcing, prompting procurement teams to re-evaluate supplier selection and inventory policies. In response, many organizations are revisiting total cost of ownership calculations to reflect duties, longer lead times, and elevated logistics risk.

Consequently, buyers are exploring alternatives such as nearshoring, supplier diversification, and longer-term contracts to mitigate exposure to tariff volatility. These approaches generally emphasize building relationships with regional manufacturers and distributors, qualifying secondary suppliers to maintain continuity, and increasing buffer inventories for critical items. Regulatory-driven requirements for validated supply chains and traceability further complicate substitution decisions, creating tension between cost mitigation and compliance. Overall, the cumulative impact of the tariffs is accelerating strategic shifts toward more resilient sourcing models, greater supply chain transparency, and heightened collaboration between procurement and laboratory operations to balance affordability with uninterrupted access to validated materials and equipment.

Delivering practical segmentation insights by synthesizing product, end user, application, sample type, and workflow drivers that determine procurement and validation priorities

A nuanced view of segmentation reveals how product type, end user, application, sample type, and workflow each shape procurement priorities and innovation adoption across the sample handling continuum. Examining product type shows that consumables, instruments, reagents and kits, and software and services occupy distinct value propositions to buyers; within instruments there is a pronounced demand for automated pipetting systems, temperature-controlled centrifuges, and vortex mixers as laboratories seek throughput gains and reproducibility, while reagents and kits such as antibodies, buffers and solutions, enzymes, and labeling and detection reagents drive assay performance and compatibility. End user diversity affects purchasing behavior, as academic and research institutes, biopharmaceutical companies, contract research organizations, diagnostic laboratories, and hospitals each apply different standards for validation, throughput, and cost control, and diagnostic laboratories in particular subdivide into clinical chemistry, hematology, microbiology, and molecular diagnostics, each with its own handling requirements.

Application-level distinctions between diagnostics, drug discovery and development, genomics, and proteomics direct investments toward tailored solutions; diagnostics further differentiates along laboratory diagnostics and point-of-care pathways, where portability and stability become pivotal. Sample type considerations, encompassing blood, cells, tissue, and urine, impose varying constraints on collection devices, preservatives, storage temperatures, and transport logistics. Finally, the workflow segmentation across analysis, collection, processing, storage, and transport underscores the need for interoperable solutions that preserve pre-analytical integrity. These overlapping segmentations demonstrate that decisions about product selection and process design must be made in the context of specific end-use cases and operational constraints to achieve both scientific rigor and economic efficiency.

Explaining how regional regulatory regimes, manufacturing capacity, and logistical infrastructure create differentiated opportunities across the Americas, EMEA, and Asia-Pacific

Regional dynamics are shaping strategic choices in sample handling as organizations weigh local regulatory frameworks, manufacturing footprints, and logistical infrastructure. In the Americas, demand patterns reflect a broad mix of high-throughput clinical laboratories, translational research centers, and biopharmaceutical R&D hubs that prioritize automation, long-term supplier relationships, and rapid access to novel reagents. Supply chain integration and the presence of large contract service providers further influence vendor selection and preferred commercial models.

Across Europe, Middle East & Africa, the landscape is heterogeneous: robust regulatory regimes and centralized healthcare systems in several European markets drive strong emphasis on compliance and validated cold chain capabilities, while emerging markets within the region often focus on affordability, reagent stability at ambient temperatures, and solutions that enable decentralized testing. In Asia-Pacific, rapid investment in genomic and proteomic research, coupled with growing domestic manufacturing capacity, is accelerating adoption of both high-end instruments and localized consumable production. Collectively, these regional differences underscore the importance of tailoring go-to-market strategies, regulatory engagement, and supply chain architecture to local conditions rather than pursuing a uniform global approach.

Identifying competitive differentiators among suppliers that combine validated product portfolios, service models, and interoperability to reduce pre-analytical variability

Competitive dynamics in the sample handling ecosystem are increasingly defined by the ability of organizations to offer integrated value propositions that span hardware, consumables, reagents, and data services. Suppliers that combine robust quality systems, regulatory support, and clear documentation for validation typically gain preference among regulated end users, while those with modular, interoperable platforms appeal to high-throughput research and industrial customers. Companies that invest in application-specific kits and reagents, along with validated protocols, reduce adoption friction and improve customer retention, particularly in diagnostic pathways and regulated drug development workflows.

Service-oriented business models, including instrument-as-a-service, reagent subscription programs, and remote monitoring, are emerging as differentiators that lower upfront capital barriers and provide predictable operational expenditure profiles. Strategic partnerships between instrument manufacturers and reagent suppliers, as well as collaborations with informatics vendors, are enabling more complete solutions that address pre-analytical variability. For procurement leaders, preferred suppliers are those that combine technical reliability, transparent quality practices, and agility in adapting to localized compliance requirements and logistical constraints.

Actionable recommendations for leaders to strengthen supply resilience, standardize validation, and scale automation to reduce pre-analytical risk and operational exposure

Industry leaders can take immediate, actionable steps to fortify sample handling operations by aligning procurement strategy, validation planning, and cross-functional governance. First, embed rigorous supplier qualification processes that evaluate documentation for lot-to-lot consistency, stability data for reagents, and traceability for consumables, while ensuring that contracts address tariff and logistics risks. Second, prioritize investments in automation where it demonstrably reduces manual error and enables consistent throughput; pair these investments with training programs that equip laboratory staff to operate and maintain automated systems effectively.

Third, adopt a risk-based approach to inventory and sourcing that blends regional supplier diversification with strategic onshore or nearshore partnerships to mitigate tariff exposure and lead time variability. Fourth, integrate environmental and chain-of-custody monitoring into laboratory informatics to provide real-time visibility into storage and transport conditions, supporting faster corrective actions and audit readiness. Finally, cultivate cross-functional steering committees composed of procurement, quality, laboratory operations, and R&D to oversee validation protocols, change controls, and supplier performance metrics. These measures collectively improve sample integrity, reduce operational disruptions, and create clearer pathways for scaling scientific operations responsibly.

Explaining a rigorous mixed-methods research methodology that integrates primary interviews, technical literature review, and expert validation to ensure actionable and accurate findings

The research approach combines structured primary engagement with targeted secondary analysis to produce a robust, evidence-based assessment of biological sample handling dynamics. Primary inputs include interviews with laboratory directors, procurement leads, quality assurance professionals, and supply chain managers to capture firsthand perspectives on pain points, adoption drivers, and validation hurdles. These conversations are framed to elicit operational details such as workflow bottlenecks, reagent stability concerns, and instrumentation uptime priorities while ensuring anonymity and confidentiality to promote candid responses.

Secondary research involves systematic review of technical literature, regulatory guidance, product documentation, and case studies to triangulate findings and test hypothesis robustness. Data synthesis emphasizes cross-validation across sources and stress-tests scenario assumptions to identify risks and opportunity levers. Where applicable, expert panels composed of experienced laboratorians and industry technologists review drafts to ensure practical relevance and technical accuracy. Finally, the methodology applies rigorous quality checks for internal consistency, logical coherence, and alignment with the latest published standards to ensure that conclusions are actionable and reflective of current operational realities.

Concluding with a clear synthesis of how coordinated investments in automation, validated reagents, and resilient sourcing secure sample integrity and operational continuity

In summary, the biological sample handling domain is at an inflection point where technological innovation, regulatory scrutiny, and supply chain dynamics converge to redefine how laboratories protect sample integrity and accelerate discovery. Organizations that proactively invest in interoperable automation, validated reagent systems, and real-time chain-of-custody monitoring will be better positioned to manage pre-analytical variability and compliance obligations. Equally important is the strategic reorientation of sourcing practices in light of tariff pressures and logistics uncertainties, which favors diversified supplier portfolios and stronger regional partnerships.

Taken together, these developments imply that operational excellence in sample handling is achieved not by isolated purchases but by coordinated programs that align procurement, quality, and laboratory operations around shared performance metrics. Leadership that fosters cross-functional governance, invests in staff capability, and prioritizes modular, validated solutions will capture the dual benefits of scientific reproducibility and operational resilience. The conclusion underscores the urgency for stakeholders to translate these insights into prioritized actions that protect scientific output and sustain organizational momentum.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Adoption of single-use bioprocessing technologies to minimize cross-contamination in biologics manufacturing
  • 5.2. Implementation of IoT-enabled cold chain monitoring devices for real-time sample integrity tracking across supply chains
  • 5.3. Expansion of decentralized point-of-care testing requiring robust sample stabilization and transport solutions
  • 5.4. Development of cryogenic sample preservation methods leveraging novel cryoprotectants to improve long-term viability
  • 5.5. Growth of laboratory automation platforms integrating AI-driven quality control for sample handling and data management

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Biological Sample Handling Market, by Product Type

  • 8.1. Consumables
  • 8.2. Instruments
    • 8.2.1. Automated Pipetting Systems
    • 8.2.2. Temperature Controlled Centrifuges
    • 8.2.3. Vortex Mixers
  • 8.3. Reagents And Kits
    • 8.3.1. Antibodies
    • 8.3.2. Buffers And Solutions
    • 8.3.3. Enzymes
    • 8.3.4. Labeling And Detection Reagents
  • 8.4. Software And Services

9. Biological Sample Handling Market, by End User

  • 9.1. Academic And Research Institutes
  • 9.2. Biopharmaceutical Companies
  • 9.3. Contract Research Organizations
  • 9.4. Diagnostic Laboratories
    • 9.4.1. Clinical Chemistry
    • 9.4.2. Hematology
    • 9.4.3. Microbiology
    • 9.4.4. Molecular Diagnostics
  • 9.5. Hospitals

10. Biological Sample Handling Market, by Application

  • 10.1. Diagnostics
    • 10.1.1. Laboratory Diagnostics
    • 10.1.2. Point Of Care
  • 10.2. Drug Discovery And Development
  • 10.3. Genomics
  • 10.4. Proteomics

11. Biological Sample Handling Market, by Sample Type

  • 11.1. Blood
  • 11.2. Cells
  • 11.3. Tissue
  • 11.4. Urine

12. Biological Sample Handling Market, by Workflow

  • 12.1. Analysis
  • 12.2. Collection
  • 12.3. Processing
  • 12.4. Storage
  • 12.5. Transport

13. Biological Sample Handling Market, by Region

  • 13.1. Americas
    • 13.1.1. North America
    • 13.1.2. Latin America
  • 13.2. Europe, Middle East & Africa
    • 13.2.1. Europe
    • 13.2.2. Middle East
    • 13.2.3. Africa
  • 13.3. Asia-Pacific

14. Biological Sample Handling Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Biological Sample Handling Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Share Analysis, 2024
  • 16.2. FPNV Positioning Matrix, 2024
  • 16.3. Competitive Analysis
    • 16.3.1. Thermo Fisher Scientific Inc.
    • 16.3.2. Danaher Corporation
    • 16.3.3. Merck KGaA
    • 16.3.4. Agilent Technologies, Inc.
    • 16.3.5. Avantor, Inc.
    • 16.3.6. Bio-Rad Laboratories, Inc.
    • 16.3.7. PerkinElmer, Inc.
    • 16.3.8. Sartorius AG
    • 16.3.9. QIAGEN N.V.
    • 16.3.10. General Electric Company

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
  • FIGURE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2024 VS 2032 (%)
  • FIGURE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
  • FIGURE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2024 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 13. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 14. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 15. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 17. EUROPE BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 18. MIDDLE EAST BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 19. AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 22. ASEAN BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 23. GCC BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 24. EUROPEAN UNION BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 25. BRICS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 26. G7 BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 27. NATO BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 28. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
  • FIGURE 29. BIOLOGICAL SAMPLE HANDLING MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 30. BIOLOGICAL SAMPLE HANDLING MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. BIOLOGICAL SAMPLE HANDLING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2018-2024 (USD MILLION)
  • TABLE 4. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, 2025-2032 (USD MILLION)
  • TABLE 5. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 6. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 8. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 9. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 10. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 11. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 12. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONSUMABLES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 13. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 14. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 15. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 16. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 17. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 18. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 19. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 20. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 21. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 22. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 23. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 24. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 25. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 26. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY AUTOMATED PIPETTING SYSTEMS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 27. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 28. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 29. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 30. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 31. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 32. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TEMPERATURE CONTROLLED CENTRIFUGES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 33. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 34. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 35. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 36. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 37. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 38. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY VORTEX MIXERS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 39. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 40. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2025-2032 (USD MILLION)
  • TABLE 41. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 42. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 43. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 44. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 45. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 46. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 47. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 50. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 52. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANTIBODIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 53. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 54. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 55. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 56. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 57. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 58. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BUFFERS AND SOLUTIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 62. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 63. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 64. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ENZYMES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 65. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 66. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 67. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 68. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 69. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 70. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABELING AND DETECTION REAGENTS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 71. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 72. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 73. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 74. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 75. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 76. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SOFTWARE AND SERVICES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 77. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 78. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 79. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 80. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 81. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 82. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 83. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 84. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 86. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 87. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 88. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 89. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 90. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BIOPHARMACEUTICAL COMPANIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 91. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 92. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 93. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 94. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 95. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 96. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 97. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 99. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 100. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 101. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 102. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 104. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 105. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 106. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 107. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 108. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 109. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 110. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CLINICAL CHEMISTRY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 111. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 112. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 113. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 114. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 115. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 116. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HEMATOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 118. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 119. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 120. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 121. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 122. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MICROBIOLOGY, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 123. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 124. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 125. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 126. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 127. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 128. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY MOLECULAR DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 129. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 130. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 131. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 132. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 133. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 134. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 135. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 136. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 137. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 138. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 139. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 140. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 141. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 142. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 143. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 144. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 145. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 146. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 147. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 148. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 149. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 150. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY LABORATORY DIAGNOSTICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 151. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 152. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 153. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 154. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 155. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 156. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY POINT OF CARE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 157. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 158. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 159. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 160. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 161. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 162. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DRUG DISCOVERY AND DEVELOPMENT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 163. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 164. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 165. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 166. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 167. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 168. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY GENOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 169. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 170. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 171. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 172. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 173. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 174. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROTEOMICS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 175. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 176. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 177. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 178. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 179. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 180. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 181. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 182. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY BLOOD, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 183. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 184. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 185. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 186. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 187. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 188. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY CELLS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 189. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 190. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 191. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 192. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 193. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 194. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TISSUE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 195. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 196. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 197. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 198. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 199. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 200. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY URINE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 201. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 202. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 203. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 204. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 205. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 206. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 207. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 208. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY ANALYSIS, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 210. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 211. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 212. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 213. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 214. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COLLECTION, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 215. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 216. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 217. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 218. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 219. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 220. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PROCESSING, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 221. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 222. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 223. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 224. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 225. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 226. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY STORAGE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 227. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 228. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 229. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY GROUP, 2018-2024 (USD MILLION)
  • TABLE 230. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY GROUP, 2025-2032 (USD MILLION)
  • TABLE 231. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 232. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY TRANSPORT, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 233. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
  • TABLE 234. GLOBAL BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REGION, 2025-2032 (USD MILLION)
  • TABLE 235. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 236. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 237. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 238. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 239. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 240. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 241. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 242. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2025-2032 (USD MILLION)
  • TABLE 243. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 244. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 245. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 246. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 247. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 248. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 249. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 250. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 251. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 252. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 253. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 254. AMERICAS BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 255. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 256. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 257. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 258. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 259. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 260. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 261. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 262. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2025-2032 (USD MILLION)
  • TABLE 263. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 264. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 265. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 266. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 267. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 268. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 269. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 270. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 271. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 272. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 273. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 274. NORTH AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 275. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
  • TABLE 276. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY COUNTRY, 2025-2032 (USD MILLION)
  • TABLE 277. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 278. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 279. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2018-2024 (USD MILLION)
  • TABLE 280. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY INSTRUMENTS, 2025-2032 (USD MILLION)
  • TABLE 281. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2018-2024 (USD MILLION)
  • TABLE 282. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY REAGENTS AND KITS, 2025-2032 (USD MILLION)
  • TABLE 283. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
  • TABLE 284. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
  • TABLE 285. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2018-2024 (USD MILLION)
  • TABLE 286. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2025-2032 (USD MILLION)
  • TABLE 287. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
  • TABLE 288. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
  • TABLE 289. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2018-2024 (USD MILLION)
  • TABLE 290. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY DIAGNOSTICS, 2025-2032 (USD MILLION)
  • TABLE 291. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2018-2024 (USD MILLION)
  • TABLE 292. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SAMPLE TYPE, 2025-2032 (USD MILLION)
  • TABLE 293. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2018-2024 (USD MILLION)
  • TABLE 294. LATIN AMERICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY WORKFLOW, 2025-2032 (USD MILLION)
  • TABLE 295. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2018-2024 (USD MILLION)
  • TABLE 296. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY SUBREGION, 2025-2032 (USD MILLION)
  • TABLE 297. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
  • TABLE 298. EUROPE, MIDDLE EAST & AFRICA BIOLOGICAL SAMPLE HANDLING MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
  • TABLE 299. EUROPE, MI